Wai-In Chan|Brian J P Huntly - JoVE Visualize

Showing results (51-60 of 100) with videos related to

Pageof 10

Sort By:

Trials|May 29, 2020

Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meetingKatharina M Lang, Kathryn L Harrison, Paula R Williamson, et al.

Haematologica|August 4, 2006

An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivationGeorge S Vassiliou, Peter J Campbell, Juan Li, et al.

Oncogene|August 24, 2005

FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse modelBenjamin H Lee, Ifor R Williams, Ema Anastasiadou, et al.

Plos One|February 8, 2011

Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemiaNicolas Bonadies, Samuel D Foster, Wai-In Chan, et al.

Cancer Cell|October 16, 2007

FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemiaBenjamin H Lee, Zuzana Tothova, Ross L Levine, et al.

Blood|May 31, 2002

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instabilityBrian J P Huntly, Anthony J Bench, Eric Delabesse, et al.

Blood|September 14, 2019

Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignanciesDaniel Sasca, Haiyang Yun, George Giotopoulos, et al.

Nature Communications|March 18, 2020

Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AMLSilvia Basilico, Xiaonan Wang, Alison Kennedy, et al.

Oncogene|August 11, 2005

FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignanciesJing Chen, Benjamin H Lee, Ifor R Williams, et al.

Blood|February 22, 2018

Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibitionPaolo Gallipoli, George Giotopoulos, Konstantinos Tzelepis, et al.

Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:

Pageof 10

Trials|May 29, 2020

Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meetingKatharina M Lang, Kathryn L Harrison, Paula R Williamson, et al.

Haematologica|August 4, 2006

An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivationGeorge S Vassiliou, Peter J Campbell, Juan Li, et al.

Oncogene|August 24, 2005

FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse modelBenjamin H Lee, Ifor R Williams, Ema Anastasiadou, et al.

Plos One|February 8, 2011

Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemiaNicolas Bonadies, Samuel D Foster, Wai-In Chan, et al.

Cancer Cell|October 16, 2007

FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemiaBenjamin H Lee, Zuzana Tothova, Ross L Levine, et al.

Blood|May 31, 2002

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instabilityBrian J P Huntly, Anthony J Bench, Eric Delabesse, et al.

Blood|September 14, 2019

Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignanciesDaniel Sasca, Haiyang Yun, George Giotopoulos, et al.

Nature Communications|March 18, 2020

Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AMLSilvia Basilico, Xiaonan Wang, Alison Kennedy, et al.

Oncogene|August 11, 2005

FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignanciesJing Chen, Benjamin H Lee, Ifor R Williams, et al.

Blood|February 22, 2018

Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibitionPaolo Gallipoli, George Giotopoulos, Konstantinos Tzelepis, et al.

Pageof 10